| P50 | author | Andrew John Lees | Q4757729 |
| | Nick C. Fox | Q37836499 |
| P2093 | author name string | Marjan Jahanshahi | |
| | Dominic C Paviour | |
| | Shona L Price | |
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| | An Inventory for Measuring Depression | Q26778503 |
| | Parkinsonism: onset, progression, and mortality | Q28259134 |
| | Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease | Q29040861 |
| | Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients | Q30688673 |
| | The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service | Q33183516 |
| | Consensus statement on the diagnosis of multiple system atrophy. | Q33605440 |
| | The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease | Q33631292 |
| | The FAB: a Frontal Assessment Battery at bedside. | Q33927821 |
| | PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA. | Q34256347 |
| | Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism | Q34405999 |
| | Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis | Q35468520 |
| | Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy. | Q35478429 |
| | The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal | Q36686188 |
| | Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. | Q37299819 |
| | Differential diagnosis and classification of apathy | Q38137420 |
| | Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing | Q38413321 |
| | Memory and information processing capacity after closed head injury | Q39257117 |
| | Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy | Q39340274 |
| | Visualisation and quantification of rates of atrophy in Alzheimer's disease. | Q39424024 |
| | Rates of cerebral atrophy in autopsy-confirmed progressive supranuclear palsy | Q40373871 |
| | Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration | Q42457537 |
| | The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations | Q42469816 |
| | Correction of differential intensity inhomogeneity in longitudinal MR images | Q44987375 |
| | The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. | Q44988048 |
| | Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy | Q48176438 |
| | Correlation between rates of brain atrophy and cognitive decline in AD. | Q48208533 |
| | Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI. | Q48239496 |
| | A modified card sorting test sensitive to frontal lobe defects | Q48346552 |
| | Longitudinal MRI study of multiple system atrophy - when do the findings appear, and what is the course? | Q48532948 |
| | Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease | Q48585450 |
| | The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. | Q48594940 |
| | Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration | Q48638179 |
| | Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. | Q48651369 |
| | Progressive cerebral atrophy in multiple system atrophy | Q48659954 |
| | Rates of global and regional cerebral atrophy in AD and frontotemporal dementia. | Q48704108 |
| | Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. | Q48722974 |
| | New and reliable MRI diagnosis for progressive supranuclear palsy | Q48830253 |
| | Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy | Q48921968 |
| | Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy | Q49023425 |
| | Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates. | Q51986386 |
| | Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease | Q57384590 |
| P433 | issue | Pt 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | magnetic resonance imaging | Q161238 |
| | progressive supranuclear palsy | Q945930 |
| | multiple system atrophy | Q1541975 |
| P304 | page(s) | 1040-1049 | |
| P577 | publication date | 2006-02-02 | |
| P1433 | published in | Brain | Q897386 |
| P1476 | title | Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy | |
| P478 | volume | 129 | |